IDRI, Duke Vax Institute, 3M Partner on Adjuvant COVID Vax
Studies show 3M-052/Alum formulation elicits a strong, durable immune response against several strains of coronavirus, including bat coronaviruses.
May 11, 2021
by contractpharma
Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine
Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced the signing of a Collaboration Agreement and License Agreement ...
October 23, 2020
by prnewswire
Baylor College and Texas Children’s to advance Covid-19 vaccine
Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development have expanded their alliance with Infectious Disease Research Institute (IDRI) to accelerate the development of a Covid-19 vaccine candidate.
June 4, 2020
by pharmaceutical-technology
iBio Expands COVID-19 Vaccine Collaboration
Now includes the Infectious Disease Research Institute to help lead pre-clinical development and clinical trial oversight.
April 14, 2020
by contractpharma
GC Pharma, IDRI, MIBR Launch Curevo
GC Pharma, a South Korean biopharmaceutical company, announced the establishment of Curevo Inc.
May 22, 2018
by contractpharma